Header Logo

Connection

Erica Browne to HIV Infections

Back to Details
This is a "connection" page, showing publications Erica Browne has written about HIV Infections.
Erica Browne
Connection Strength
5.532
HIV Infections
  1. Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 2024 01; 36(1):80-86.
    View in: PubMed
    Score: 0.554
  2. Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023 02 10; 23(1):58.
    View in: PubMed
    Score: 0.547
  3. Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):418-424.
    View in: PubMed
    Score: 0.528
  4. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451.
    View in: PubMed
    Score: 0.451
  5. Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):415-424.
    View in: PubMed
    Score: 0.167
  6. Longer-acting preexposure prophylaxis product and delivery preferences among transgender women in the United States: a discrete choice experiment. AIDS. 2025 Nov 15; 39(14):2140-2142.
    View in: PubMed
    Score: 0.165
  7. Measuring Pre-Exposure Prophylaxis (PrEP) Stigma Among Adolescent Girls and Young Women in Western Kenya: Scale Development, Validation, and Associations with PrEP Adherence. AIDS Patient Care STDS. 2025 Aug; 39(8):323-338.
    View in: PubMed
    Score: 0.162
  8. Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment. AIDS. 2025 Aug 01; 39(10):1364-1374.
    View in: PubMed
    Score: 0.160
  9. PrEP knowledge, attitudes, and perceived barriers to access among American Indian/Alaska Native people in the US: Results from an online survey. PLoS One. 2025; 20(4):e0321422.
    View in: PubMed
    Score: 0.160
  10. Evaluation of the Tu'Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 01; 14:e55931.
    View in: PubMed
    Score: 0.159
  11. We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
    View in: PubMed
    Score: 0.152
  12. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. AIDS Behav. 2024 Sep; 28(9):2990-3000.
    View in: PubMed
    Score: 0.150
  13. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial. J Int AIDS Soc. 2023 12; 26(12):e26198.
    View in: PubMed
    Score: 0.145
  14. The Effects of Participation in an Intensive HIV Prevention Trial on Long-Term Socio-Demographic Outcomes Among Young Women in Rural South Africa. J Acquir Immune Defic Syndr. 2023 05 01; 93(1):1-6.
    View in: PubMed
    Score: 0.139
  15. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS Behav. 2022 Dec; 26(12):3848-3861.
    View in: PubMed
    Score: 0.135
  16. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):425-433.
    View in: PubMed
    Score: 0.132
  17. Couples' decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention. AIDS Behav. 2023 Jan; 27(1):198-207.
    View in: PubMed
    Score: 0.131
  18. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS One. 2022; 17(2):e0263664.
    View in: PubMed
    Score: 0.128
  19. Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis. J Acquir Immune Defic Syndr. 2022 02 01; 89(2):172-177.
    View in: PubMed
    Score: 0.127
  20. The Role of Families in Adolescent and Young Adults' PrEP Use. AIDS Behav. 2022 May; 26(5):1618-1632.
    View in: PubMed
    Score: 0.125
  21. Improved syringe disposal practices associated with unsanctioned safe consumption site use: A cohort study of people who inject drugs in the United States. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109075.
    View in: PubMed
    Score: 0.125
  22. Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth. J Acquir Immune Defic Syndr. 2021 07 01; 87(3):928-936.
    View in: PubMed
    Score: 0.122
  23. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav. 2021 Aug; 25(8):2430-2440.
    View in: PubMed
    Score: 0.120
  24. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020 06; 23(6):e25528.
    View in: PubMed
    Score: 0.114
  25. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020 Feb; 24(2):617-628.
    View in: PubMed
    Score: 0.111
  26. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S222-S229.
    View in: PubMed
    Score: 0.110
  27. First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):304-310.
    View in: PubMed
    Score: 0.107
  28. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
    View in: PubMed
    Score: 0.105
  29. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):394-403.
    View in: PubMed
    Score: 0.105
  30. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018 03; 21(3):e25094.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.